Harvey Hoyt has been promoted to chief executive officer atMicroProbe Corp., replacing John Bishop, who resigned. Also,Allan Cochrane has been promoted to president and chiefoperating officer. They were both appointed to the Bothell,Wash., company's board of directors. Hoyt was president andchief operating officer of MicroProbe's therapeutics divisionand Cochrane was vice president of sales and marketing of thediagnostics division.

Boston Life Sciences Inc. of Waltham, Mass., named its founder,Marc Lanser, president and chief executive officer. In addition,the company named Robert Tidwell, formerly vice president ofmarketing and business development at Genetics Institute Inc.,executive vice president and chief operating officer.

Robert Funari was named executive vice president and chiefoperating officer of Syncor International Corp. of Chatsworth,Calif. Funari was executive vice president and general managerof McKesson Drug Company, a subsidiary of McKesson Inc.

Cambrex Hydrogels of Harriman, N.Y., (which had been knownas the Hydrogels operating unit of Nepera Inc.) appointedAlbert Eilender as president; John D'Antonio as director ofsales, marketing and new business development; SarahBingman as manager of operations; and Adrian Fox as managerof polymer research and development. Parexel InternationalCorp. of Waltham, Mass., named Barry Philpott president,European operations. Philpott was general manager of EG&GInc.'s worldwide optical and analytic division.

Paul Wilson has been named president and chief executiveofficer of Vaxcel, the wholly owned vaccine subsidiary ofCytRx Corp. of Norcross, Ga. Wilson had been vice president andgeneral manager of American Cyanamid's Lederle-Praxisbiologicals division.

BioSurface Technology Inc. of Cambridge, Mass., namedAugustine Lawlor chief financial officer. Lawlor joinsBioSurface from Armstrong Pharmaceuticals Inc., where he wasvice president, chief financial officer and corporate secretary.

GeneMedicine Inc. of Houston named scientific founder FredLedley vice president of clinical research and development.Ledley has been one of the company's scientific consultants.

Isis Pharmaceuticals Inc. of Carlsbad, Calif., promoted DavidEcker to vice president of biology and P. Dan Cook to vicepresident of chemistry.

Janet Hanlon has been promoted to treasurer and controller ofUnivax Biologics Inc. of Rockville, Md.

(c) 1997 American Health Consultants. All rights reserved.